The new online system enables patients to share their feedback and experiences who are looking for or who are participating in clinical trials.
OncoSec, along with Smart Patients, is creating a community for patients suffering from Merkel cell carcinoma (MCC), a rare form of skin cancer that currently has no approved therapies.
OncoSec CEO Punit Dhillon said that one of the most frightening parts of being diagnosed with a rare disease like MCC is a lack of information about the condition and treatment options.
The company is conducting the active Phase II immunotherapy trial.
Smart Patients CEO and co-founder Roni Zeiger said, "Together with OncoSec, we will be able to gain a better understanding of MCC from a patient perspective, and help design more patient-centered trials that will make scientific breakthroughs for this disease available sooner."
Smart Patients, an online community for cancer patients and caregivers, includes a clinical trial search engine that presents trial data from ClinicalTrials.gov in a patient-friendly format.
